Since this observation, gene fusions involving NTRK1, 2, and 3 genes have been documented in 11 specific tumor types, most notably NSCLC, papillary thyroid carcinoma [38], secretory breast cancer [39], and glioblastoma [40,41]. The gene discussed is NTRK1; the disease is glioblastoma.